Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model to Study Trypanosoma cruzi Infection.

  • A Bozzi
  • , N Sayed
  • , E Matsa
  • , G Sass
  • , E Neofytou
  • , Clemons KV
  • , R Correa-Oliveira
  • , Stevens DA
  • , Wu JC

Research output: Contribution to journalArticlepeer-review

Abstract

Chagas disease (ChD) is one of the most neglected tropical diseases, with cardiomyopathy being the main cause of death in Trypanosoma cruzi-infected patients. As the parasite actively replicates in cardiomyocytes (CMs), the heart remains a key target organ in the pathogenesis of ChD. Here we modeled ChD using human induced pluripotent stem cell-derived CMs (iPSC-CMs) to understand the complex interplay between the parasite and host cells. We showed that iPSC-CMs can get infected with the T. cruzi Y strain and that all parasite cycle stages can be identified in our model system. Importantly, characterization of T. cruzi-infected iPSC-CMs showed significant changes in their gene expression profile, cell contractility, and distribution of key cardiac markers. Moreover, these infected iPSC-CMs exhibited a pro-inflammatory profile as indicated by significantly elevated cytokine levels and cell-trafficking regulators. We believe our iPSC-CM model is a valuable platform to explore new treatment strategies for ChD.
Original languageUndefined/Unknown
Pages (from-to)1232-1241
Number of pages10
JournalStem Cell Reports
Volume12
Issue number6
DOIs
Publication statusPublished - 16 May 2019

Keywords

  • cardiomyopathy
  • Chagas disease
  • disease modeling
  • drug screening
  • induced pluripotent stem cells
  • Trypanosoma cruzi

Cite this